Old Web
English
Sign In
Acemap
>
authorDetail
>
C. A. Bulanhagui
C. A. Bulanhagui
Melanoma
Pathology
Medicine
Tremelimumab
in patient
3
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I dose escalation trial of tremelimumab (CP-675,206) administered in combination with PF-3512676 in patients with melanoma or other advanced cancers
2016
Journal of Clinical Oncology
Craig Underhill
Michael Millward
S. Lobb
J. McBurnie
S.J. Meech
Jesus Gomez-Navarro
David Robert John Readett
C. A. Bulanhagui
Show All
Source
Cite
Save
Citations (3)
Pharmacogenetic analysis of CTLA4 gene polymorphisms and response to tremelimumab in patients with advanced melanoma
2008
Journal of Clinical Oncology
J. Richmond
F. Gao
L. Wood
C. A. Bulanhagui
M Penny
Show All
Source
Cite
Save
Citations (0)
Natural history of diarrhea associated with the anti-CTLA4 monoclonal antibody CP-675,206
2007
Journal of Clinical Oncology
Scott Antonia
Jeffrey A. Sosman
John M. Kirkwood
Bruce G. Redman
Thomas F. Gajewski
Dmitri Pavlov
C. A. Bulanhagui
Luis H. Camacho
Antoni Ribas
Show All
Source
Cite
Save
Citations (8)
1